*** Results codebook ***
We report simulation results for 2015-2030 for 2 scenarios: COVID-19 (status quo) and a counterfactual scenario of no COVID-19 in which the impacts of 
COVID-19 on excess mortality and cancer detection were removed.  Scenario names are used as prefixes for file names.  
We report the mean and 95% uncertainty intervals of our simulation results.

Simulation results are reported for five cancers in Chile:

|Code |Cancer    |
|-----|----------|
|0    |Breast    |
|1    |Cervix    |
|2    |Colorectal|
|3    |Prostate  |
|4    |Stomach   |


**** monthlyCasesDeaths ****
Reports the number of detected cancer cases and deaths by month.

Column headers

|Column Label      |Description                                                 |
|------------------|------------------------------------------------------------|
|year              |Year (2015-2030)                                            |
|month             |Month (1=Jan, ..., 12=Dec)                                  |
|cancer            |0=Breast, 1=Cervix, 2=Colorectal, 3=Prostate, 4=Stomach     |
|casesDetected_Mean|Estimated cases detected - mean                             |
|casesDetected_LB  |Estimated cases detected - 95% UI lower bound               |
|casesDetected_UB  |Estimated cases detected - 95% UI upper bound               |
|deaths_Mean       |Estimated cancer deaths - mean                              |
|deaths_LB         |Estimated cancer deaths - 95% UI lower bound                |
|deaths_UB         |Estimated cancer deaths - 95% UI upper bound                |

**** yearlyStage ****
Reports the stage distribution (I-IV) at diagnosis by year

Column headers

|Column Label      |Description                                                 |
|------------------|------------------------------------------------------------|
|year              |Year (2015-2030)                                            |
|cancer            |0=Breast, 1=Cervix, 2=Colorectal, 3=Prostate, 4=Stomach     |
|sex               |-1=Both, 0=Male, 1=Female                                   |
|I_Mean            |Estimated proportion of Stage I cases, mean                 |
|II_Mean           |Estimated proportion of Stage II cases, mean                |
|III_Mean          |Estimated proportion of Stage III cases, mean               |
|IV_Mean           |Estimated proportion of Stage IV cases, mean                |
|I_LB              |Estimated proportion of Stage I cases, 95% UI lower bound   |
|II_LB             |Estimated proportion of Stage II cases, 95% UI lower bound  |
|III_LB            |Estimated proportion of Stage III cases, 95% UI lower bound |
|IV_LB             |Estimated proportion of Stage IV cases, 95% UI lower bound  |
|I_UB              |Estimated proportion of Stage I cases, 95% UI upper bound   |
|II_UB             |Estimated proportion of Stage II cases, 95% UI upper bound  |
|III_UB            |Estimated proportion of Stage III cases, 95% UI upper bound |
|IV_UB             |Estimated proportion of Stage IV cases, 95% UI upper bound  |

**** yearlySurvDeaths ****
Reports 5-year net survival and cancer deaths by year

Column headers

|Column Label      |Description                                                 |
|------------------|------------------------------------------------------------|
|year              |Year (2015-2030)                                            |
|cancer            |0=Breast, 1=Cervix, 2=Colorectal, 3=Prostate, 4=Stomach     |
|surv_Mean         |Estimated 5-year net survival - mean                        |
|surv_LB           |Estimated 5-year net survival - 95% UI lower bound          |
|surv_UB           |Estimated 5-year net survival - 95% UI upper bound          |
|deaths_Mean       |Estimated cancer deaths - mean                              |
|deaths_LB         |Estimated cancer deaths - 95% UI lower bound                |
|deaths_UB         |Estimated cancer deaths - 95% UI upper bound                |


*** Citation ***
Ward ZJ, Walbaum M, Walbaum B, Guzman MJ, de la Jara JJ, Nervi B, Atun R.
Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
Lancet Oncol 2021; In Press.